Winton Group’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-74,675
| Closed | -$2.48M | – | 1099 |
|
2022
Q4 | $2.48M | Buy |
74,675
+11,911
| +19% | +$396K | 0.16% | 156 |
|
2022
Q3 | $1.98M | Buy |
62,764
+47,679
| +316% | +$1.5M | 0.13% | 208 |
|
2022
Q2 | $459K | Buy |
+15,085
| New | +$459K | 0.02% | 711 |
|
2021
Q1 | – | Sell |
-11,015
| Closed | -$206K | – | 1469 |
|
2020
Q4 | $206K | Buy |
+11,015
| New | +$206K | 0.01% | 1186 |
|
2020
Q2 | – | Sell |
-202,869
| Closed | -$1.7M | – | 1630 |
|
2020
Q1 | $1.7M | Buy |
202,869
+80,768
| +66% | +$678K | 0.05% | 629 |
|
2019
Q4 | $1.19M | Buy |
122,101
+72,890
| +148% | +$712K | 0.02% | 997 |
|
2019
Q3 | $467K | Buy |
49,211
+20,925
| +74% | +$199K | 0.01% | 1115 |
|
2019
Q2 | $336K | Buy |
+28,286
| New | +$336K | 0.01% | 848 |
|
2019
Q1 | – | Sell |
-214,511
| Closed | -$3.72M | – | 1217 |
|
2018
Q4 | $3.72M | Buy |
+214,511
| New | +$3.72M | 0.08% | 277 |
|